Best Practice Approach for Assessment of Microchip-associated Tumors in Preclinical Safety Studies: Position of the Registry of Industrial Toxicology Animal-data (RITA)

Toxicol Pathol. 2018 Oct;46(7):728-734. doi: 10.1177/0192623318792541. Epub 2018 Sep 3.

Abstract

Microchip (passive radio-frequency identification device) implantation is a common and widely employed means of animal identification in laboratory animal facilities. However, these devices have been associated with tumors of the skin and subcutis in rodents. While microchip-associated tumors are rare, they pose a challenge for accurate diagnosis and documentation in preclinical toxicity studies. Documentation of these tumors should differentiate microchip-associated lesions with spontaneously occurring or test article-induced tumors. Standardizing criteria for microchip-associated lesions will aid the diagnostic process and allow for preclinical regulatory standardization. To this end, the Registry of Industrial Toxicology Animal-data have developed clear recommendations for diagnosis and documentation of microchip-associated lesions.

Keywords: INHAND; RITA; best practice recommendations; implantation; microchip-associated tumors; recording; sampling; soft tissue tumors.

Publication types

  • Review

MeSH terms

  • Animal Identification Systems / standards*
  • Animal Identification Systems / veterinary*
  • Animals
  • Animals, Laboratory*
  • Databases, Factual
  • Guidelines as Topic
  • Lab-On-A-Chip Devices / adverse effects*
  • Lab-On-A-Chip Devices / veterinary
  • Radio Frequency Identification Device / standards*
  • Soft Tissue Neoplasms / etiology*
  • Soft Tissue Neoplasms / pathology
  • Soft Tissue Neoplasms / veterinary
  • Toxicology